CRISPR activation promises reversible gene therapy, yet design constraints have limited its clinical translation. A novel inducible system now addresses these long-standing barriers. Read more here.

Every movement we make, such as taking a walk, sending a text or hugging someone we love, depends on specialised nerve cells called motor neurones. ALS damages these neurones, and TDP-43 may be the one to blame.